Cocrystal Total Assets from 2010 to 2024

COCP Stock

USD 2.07 0.03 1.43%

Cocrystal Pharma Total Assets yearly trend continues to be relatively stable with very little volatility. Total Assets are likely to drop to about 29.7 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2007-09-30

Previous Quarter

21.6 M

Current Value

16.2 M

Quarterly Volatility

77.6 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Cocrystal Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cocrystal Pharma's main balance sheet or income statement drivers, such as Interest Expense of 1.7 K, Selling General Administrative of 4.1 M or Selling And Marketing Expenses of 8.9 M, as well as many indicators such as Price To Sales Ratio of 383, Dividend Yield of 0.0 or PTB Ratio of 0.6. Cocrystal financial statements analysis is a perfect complement when working with Cocrystal Pharma Valuation or Volatility modules.

Check out the analysis of Cocrystal Pharma Correlation against competitors.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Latest Cocrystal Pharma's Total Assets Growth Pattern

Below is the plot of the Total Assets of Cocrystal Pharma over the last few years. Total assets refers to the total amount of Cocrystal Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cocrystal Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Cocrystal Pharma's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cocrystal Pharma's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 31.26 M

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Cocrystal Total Assets Regression Statistics

	Arithmetic Mean	72,250,527
	Geometric Mean	30,341,102
	Coefficient Of Variation	109.72
	Mean Deviation	59,728,182
	Median	40,840,000
	Standard Deviation	79,274,721
	Sample Variance	6284.5T
	Range	259.1M
	R-Value	(0.05)
	Mean Square Error	6750.2T
	R-Squared	0
	Significance	0.86
	Slope	(907,677)
	Total Sum of Squares	87982.7T

Cocrystal Total Assets History

	2024	29.7 M
	2023	31.3 M
	2022	40.8 M
	2021	79.4 M
	2020	54.2 M
	2019	28.5 M
	2018	68.6 M

Other Fundumenentals of Cocrystal Pharma

Intangibles To Total Assets

Cocrystal Pharma Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Net Receivables	Good Will	Short Term Debt	Intangible Assets	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Long Term Debt	Short Term Investments	Long Term Debt Total	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Property Plant Equipment	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.58	0.03	0.2	0.24	0.77	-0.1	0.57	-0.14	0.68	0.34	0.6	-0.47	0.91	0.05	0.06	-0.15	0.07	0.03	0.14	-0.02	-0.21	0.34	-0.18	0.07
Total Stockholder Equity	0.58		-0.21	-0.22	0.5	-0.06	0.13	0.68	0.12	0.5	-0.31	0.16	-0.52	0.52	0.58	-0.43	-0.7	-0.42	-0.46	-0.12	-0.55	0.02	0.09	0.07	0.18
Net Debt	0.03	-0.21		0.75	0.05	0.19	-0.99	0.13	0.33	0.33	0.45	0.0	0.4	-0.31	-0.66	0.58	0.56	0.58	0.57	0.36	0.59	-0.7	0.55	-0.98	-0.48
Retained Earnings	0.2	-0.22	0.75		-0.08	0.39	-0.74	0.23	-0.17	0.31	0.76	0.13	0.55	-0.06	-0.89	0.9	0.83	0.91	0.88	0.67	0.9	-0.71	0.88	-0.75	-0.06
Accounts Payable	0.24	0.5	0.05	-0.08		-0.08	-0.04	0.39	-0.06	-0.04	-0.22	-0.02	-0.05	0.26	0.29	-0.06	-0.35	-0.06	-0.08	-0.19	-0.2	0.18	-0.14	-0.1	-0.12
Total Liab	0.77	-0.06	0.19	0.39	-0.08		-0.21	0.17	-0.26	0.43	0.65	0.62	-0.19	0.72	-0.38	0.4	0.35	0.4	0.39	0.21	0.39	-0.27	0.33	-0.27	-0.07
Total Current Assets	-0.1	0.13	-0.99	-0.74	-0.04	-0.21		-0.18	-0.31	-0.41	-0.44	-0.02	-0.34	0.26	0.61	-0.54	-0.5	-0.54	-0.52	-0.4	-0.54	0.69	-0.56	0.99	0.44
Common Stock	0.57	0.68	0.13	0.23	0.39	0.17	-0.18		0.06	0.53	0.17	0.3	-0.25	0.43	0.09	0.06	-0.2	0.07	0.03	0.13	-0.03	-0.21	0.41	-0.27	0.03
Net Receivables	-0.14	0.12	0.33	-0.17	-0.06	-0.26	-0.31	0.06		0.02	-0.43	-0.41	-0.01	-0.27	0.23	-0.4	-0.28	-0.4	-0.4	-0.22	-0.34	-0.28	-0.07	-0.27	-0.46
Good Will	0.68	0.5	0.33	0.31	-0.04	0.43	-0.41	0.53	0.02		0.42	0.64	-0.56	0.39	-0.04	0.05	-0.08	0.05	0.01	0.32	0.0	-0.41	0.48	-0.47	0.06
Short Term Debt	0.34	-0.31	0.45	0.76	-0.22	0.65	-0.44	0.17	-0.43	0.42		0.67	0.11	0.23	-0.78	0.83	0.76	0.83	0.81	0.45	0.82	-0.52	0.64	-0.49	-0.11
Intangible Assets	0.6	0.16	0.0	0.13	-0.02	0.62	-0.02	0.3	-0.41	0.64	0.67		-0.62	0.6	-0.11	0.21	0.06	0.21	0.21	-0.01	0.14	-0.1	0.15	-0.13	-0.08
Current Deferred Revenue	-0.47	-0.52	0.4	0.55	-0.05	-0.19	-0.34	-0.25	-0.01	-0.56	0.11	-0.62		-0.51	-0.65	0.62	0.68	0.62	0.63	0.28	0.66	-0.35	0.38	-0.27	-0.1
Net Tangible Assets	0.91	0.52	-0.31	-0.06	0.26	0.72	0.26	0.43	-0.27	0.39	0.23	0.6	-0.51		0.21	-0.05	-0.25	-0.05	-0.06	-0.09	-0.14	0.04	0.09	0.18	0.11
Capital Surpluse	0.05	0.58	-0.66	-0.89	0.29	-0.38	0.61	0.09	0.23	-0.04	-0.78	-0.11	-0.65	0.21		-0.92	-0.97	-0.92	-0.94	-0.47	-0.96	0.62	-0.7	0.6	0.16
Long Term Debt	0.06	-0.43	0.58	0.9	-0.06	0.4	-0.54	0.06	-0.4	0.05	0.83	0.21	0.62	-0.05	-0.92		0.92	1.0	0.99	0.52	0.98	-0.56	0.7	-0.55	-0.13
Short Term Investments	-0.15	-0.7	0.56	0.83	-0.35	0.35	-0.5	-0.2	-0.28	-0.08	0.76	0.06	0.68	-0.25	-0.97	0.92		0.92	0.92	0.51	0.98	-0.53	0.61	-0.48	-0.11
Long Term Debt Total	0.07	-0.42	0.58	0.91	-0.06	0.4	-0.54	0.07	-0.4	0.05	0.83	0.21	0.62	-0.05	-0.92	1.0	0.92		0.99	0.52	0.98	-0.56	0.71	-0.56	-0.13
Deferred Long Term Liab	0.03	-0.46	0.57	0.88	-0.08	0.39	-0.52	0.03	-0.4	0.01	0.81	0.21	0.63	-0.06	-0.94	0.99	0.92	0.99		0.42	0.98	-0.56	0.68	-0.54	-0.16
Long Term Investments	0.14	-0.12	0.36	0.67	-0.19	0.21	-0.4	0.13	-0.22	0.32	0.45	-0.01	0.28	-0.09	-0.47	0.52	0.51	0.52	0.42		0.54	-0.3	0.59	-0.37	0.33
Short Long Term Debt	-0.02	-0.55	0.59	0.9	-0.2	0.39	-0.54	-0.03	-0.34	0.0	0.82	0.14	0.66	-0.14	-0.96	0.98	0.98	0.98	0.98	0.54		-0.57	0.69	-0.54	-0.12
Property Plant Equipment	-0.21	0.02	-0.7	-0.71	0.18	-0.27	0.69	-0.21	-0.28	-0.41	-0.52	-0.1	-0.35	0.04	0.62	-0.56	-0.53	-0.56	-0.56	-0.3	-0.57		-0.79	0.69	0.45
Net Invested Capital	0.34	0.09	0.55	0.88	-0.14	0.33	-0.56	0.41	-0.07	0.48	0.64	0.15	0.38	0.09	-0.7	0.7	0.61	0.71	0.68	0.59	0.69	-0.79		-0.57	0.1
Net Working Capital	-0.18	0.07	-0.98	-0.75	-0.1	-0.27	0.99	-0.27	-0.27	-0.47	-0.49	-0.13	-0.27	0.18	0.6	-0.55	-0.48	-0.56	-0.54	-0.37	-0.54	0.69	-0.57		0.46
Capital Stock	0.07	0.18	-0.48	-0.06	-0.12	-0.07	0.44	0.03	-0.46	0.06	-0.11	-0.08	-0.1	0.11	0.16	-0.13	-0.11	-0.13	-0.16	0.33	-0.12	0.45	0.1	0.46

Click cells to compare fundamentals

About Cocrystal Pharma Financial Statements

Cocrystal Pharma shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Cocrystal Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Cocrystal Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cocrystal Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	31.3 M	29.7 M
Intangibles To Total Assets	0.22	0.21

Pair Trading with Cocrystal Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Cocrystal Stock

0.57	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.55	HLN	Haleon plc	Pair Corr
0.49	BCH	Banco De Chile	Pair Corr
0.48	SHG	Shinhan Financial	Pair Corr
0.44	JNJ	Johnson Johnson Sell-off Trend	Pair Corr

The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.

The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC